EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.24.86 | (3R,4R)-N-hydroxy-4-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]tetrahydro-2H-pyran-3-carboxamide | - |
Sus scrofa | |
3.4.24.86 | (3R,4S)-N-hydroxy-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]piperidine-4-carboxamide | - |
Sus scrofa | |
3.4.24.86 | (3S,4R)-N-hydroxy-4-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]piperidine-3-carboxamide | - |
Sus scrofa | |
3.4.24.86 | (3S,4S)-1-tert-butyl-N-hydroxy-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]piperidine-4-carboxamide | - |
Sus scrofa | |
3.4.24.86 | (3S,4S)-1-[2-(dimethylamino)ethyl]-N-hydroxy-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]piperidine-4-carboxamide | - |
Sus scrofa | |
3.4.24.86 | (3S,4S)-N-hydroxy-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]piperidine-4-carboxamide | - |
Sus scrofa | |
3.4.24.86 | (3S,4S)-N-hydroxy-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]tetrahydro-2H-pyran-4-carboxamide | - |
Sus scrofa | |
3.4.24.86 | 2,6-anhydro-3,4,5-trideoxy-1-(hydroxyamino)-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]-D-threo-hexose | - |
Sus scrofa | |
3.4.24.86 | N-[(1R,2S)-2-(hydroxycarbamoyl)cyclopentyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide | - |
Sus scrofa | |
3.4.24.86 | N-[(1S,2R)-2-(hydroxycarbamoyl)cyclopentyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide | - |
Sus scrofa | |
3.4.24.86 | N-[2-(hydroxycarbamoyl)cyclobutyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide | - |
Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.24.86 | Sus scrofa | - |
- |
- |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.24.86 | TACE | - |
Sus scrofa |
3.4.24.86 | tumor necrosis factor alpha-converting enzyme | - |
Sus scrofa |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.4.24.86 | 0.000001 | - |
- |
Sus scrofa | (3R,4R)-N-hydroxy-4-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]tetrahydro-2H-pyran-3-carboxamide | |
3.4.24.86 | 0.000001 | - |
- |
Sus scrofa | (3S,4S)-N-hydroxy-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]piperidine-4-carboxamide | |
3.4.24.86 | 0.000001 | - |
- |
Sus scrofa | N-[(1S,2R)-2-(hydroxycarbamoyl)cyclopentyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide | |
3.4.24.86 | 0.000001 | - |
- |
Sus scrofa | N-[2-(hydroxycarbamoyl)cyclobutyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide | |
3.4.24.86 | 0.000001 | - |
IC50 below 0.000001 mM | Sus scrofa | (3R,4S)-N-hydroxy-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]piperidine-4-carboxamide | |
3.4.24.86 | 0.000001 | - |
IC50 below 0.000001 mM | Sus scrofa | (3S,4S)-N-hydroxy-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]tetrahydro-2H-pyran-4-carboxamide | |
3.4.24.86 | 0.000002 | - |
- |
Sus scrofa | (3S,4S)-1-[2-(dimethylamino)ethyl]-N-hydroxy-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]piperidine-4-carboxamide | |
3.4.24.86 | 0.000002 | - |
- |
Sus scrofa | (3S,4S)-1-tert-butyl-N-hydroxy-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]piperidine-4-carboxamide | |
3.4.24.86 | 0.000003 | - |
- |
Sus scrofa | 2,6-anhydro-3,4,5-trideoxy-1-(hydroxyamino)-3-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]-D-threo-hexose | |
3.4.24.86 | 0.000024 | - |
- |
Sus scrofa | (3S,4R)-N-hydroxy-4-[([4-[(2-methylquinolin-4-yl)methoxy]phenyl]carbonyl)amino]piperidine-3-carboxamide | |
3.4.24.86 | 0.0002 | - |
- |
Sus scrofa | N-[(1R,2S)-2-(hydroxycarbamoyl)cyclopentyl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide |